TWAPFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Towa Pharmaceutical Co., Ltd.

$16.83+0.00%(+$0.00)

TickerSpark Score

52/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TWAPF research report →

52-Week Range0% of range

Low $16.83

Current $16.83

High $25.33

Companywww.towayakuhin.co.jp

Towa Pharmaceutical Co. , Ltd. , together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

CEO: Itsuro Yoshida
IPO: 2009
Employees: 4,588
HQ: Osaka, JP

Price Chart

+0.00% · this period

Valuation

Market Cap: $828.51M
P/E: 36.01
P/S: 0.69
P/B: 1.06
EV/EBITDA: 8.06
Div Yield: 2.08%

Profitability

Gross Margin: 36.21%
Op Margin: 8.44%
Net Margin: 1.92%
ROE: 2.92%
ROIC: 2.25%

Growth & Income

Revenue: $275.43B · 6.10%
Net Income: $5.28B · -72.17%
EPS: $107.05 · -72.25%
Op Income: $23.25B
FCF YoY: 204.87%

Performance & Tape

52W High: $25.33
52W Low: $16.83
50D MA: $16.83
200D MA: $16.83
Beta: -0.10
Avg Volume: 95.2

Get TickerSpark's AI analysis on TWAPF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime